Kwick Forensic Solutions IPO Day 2: GMP ₹63

Welcome back to our daily check-in on the Kwick Forensic Solutions SME IPO, which is currently open for subscription on the BSE. As we enter Day 2 of the IPO period, which runs from August 27th to August 31st, 2026, the subscription numbers are still showing zero across all categories. This is a common scenario for many SME IPOs, especially in the initial days, but it’s always worth a closer look to understand what it signifies.

Subscription Status

As of Day 2, Kwick Forensic Solutions has recorded zero subscriptions in the Retail, Non-Institutional Investor (NII), and Qualified Institutional Buyer (QIB) segments, leading to a total subscription of 0x. For a Small and Medium Enterprise (SME) IPO, seeing no subscriptions on Day 2 might initially seem concerning. However, it’s crucial to remember that the bulk of the action often happens in the last couple of days. Many investors, particularly HNIs and institutional players, tend to wait until the eleventh hour to gauge the overall sentiment and make their decisions. For retail investors, the lower price point and the lot size of 1600 shares mean they’re looking for strong indications before committing. The absence of any subscription right now doesn’t necessarily spell doom, but it does mean the company and its bookrunners will be hoping for a significant surge in interest over the next three days.

GMP Update

The Grey Market Premium (GMP) for Kwick Forensic Solutions IPO has remained steady at ₹63 for Day 2, unchanged from yesterday. This consistent GMP is a positive sign, indicating that the market sentiment hasn’t deteriorated overnight. At an issue price of ₹90, a GMP of ₹63 suggests an expected listing price of ₹153 (Issue Price + GMP). This potential listing gain of approximately 70% (₹63 / ₹90 * 100) is quite attractive and has likely been a key driver of interest for many potential investors. The fact that the GMP hasn’t dipped, despite the zero subscription numbers, is encouraging. It suggests that the underlying demand for the stock in the grey market remains robust, independent of the official subscription figures at this early stage.

Should You Apply?

The decision to apply for the Kwick Forensic Solutions IPO hinges on a few key factors. On one hand, the GMP is showing a very healthy potential listing gain, which is a significant draw for short-term traders and investors looking for quick returns. The consistent GMP on Day 2 is a good indicator that this premium is holding firm. However, the complete lack of subscription on the first two days is something to monitor closely. This could mean that investors are adopting a wait-and-watch approach, or it could signal lower-than-expected retail interest at this point. It’s always wise to remember that GMP is an unofficial indicator and can be volatile. As per SEBI guidelines, investors should conduct thorough due diligence and not solely rely on GMP. Consider the company’s fundamentals, its business model, and its future prospects alongside the current market sentiment. The next few days will be critical in determining the true demand for this IPO.

View Full Kwick Forensic Solutions IPO Details